Skip to main content

Table 2 Median (Q1–Q3) volumes of study fluid (mL) delivered to cardiac surgical patients who were randomised to receive succinylated gelatin (4%) (GEL) or compound sodium lactate (CSL) as fluid resuscitation therapy after cardiac surgery between different urine sampling time points

From: A randomised controlled trial of succinylated gelatin (4%) fluid on urinary acute kidney injury biomarkers in cardiac surgical patients

Outcome

T0–T1

T1–T5

T5–T24

Total

P valuea

Fluid volume (mL)

 

 GEL

500 (500–500)

125 (0–500)

250 (0–1000)

1250 (500–1750)

 

 CSL

500 (500–500)

125 (0–500)

250 (0–500)

1000 (500–1375)

0.42

  1. aDifference between treatment groups in total volume of fluid given during study period (Wilcoxon rank-sum test)